Introduction to statistics in pharmaceutical clinical trials / (Record no. 3461)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03524nam a2200241Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | NULRC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250520094822.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 250520s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780853697145 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | NULRC |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | R 853 .D87 2008 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Durham, Todd A. |
| Relator term | author |
| 245 #0 - TITLE STATEMENT | |
| Title | Introduction to statistics in pharmaceutical clinical trials / |
| Statement of responsibility, etc. | Todd A. Durham and J. Rick Turner |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | London, United Kingdom : |
| Name of publisher, distributor, etc. | Pharmaceutical Press, |
| Date of publication, distribution, etc. | c2008 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | xiii, 226 pages : |
| Other physical details | illustrations ; |
| Dimensions | 25 cm. |
| 365 ## - TRADE PRICE | |
| Price amount | USD3595 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Includes index. |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 1. The discipline of statistics: introduction and terminology 2. The role of clinical trials in new drug development 3. Research questions and research hypotheses 4. Study design and experimental methodology 5. Data, central tendency and variation 6. Probability, hypothesis testing and estimation 7. Early phase clinical trials 8. Confirmatory clinical trials: safety data 1 9. Confirmatory clinical trials: safety data II 10. Confirmatory clinical trials: analysis of categorical efficacy data 11. Confirmatory clinical trials: analysis of continuous efficacy data 12. Additional statistical considerations in clinical trials 13. Concluding remarks Appendices |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | A self-contained introduction to Statistics, presented in the context of clinical trials and pharmaceutical drug development. This title focuses on the statistical analyses most commonly used in drug development. It emphasises the importance of descriptive statistics as well as inferential statistics. This book is a self-contained introduction to Statistics, presented in the context of clinical trials and pharmaceutical drug development. It focuses on the statistical analyses most commonly used in drug development and is therefore an ideal introduction to pharmaceutical statistics. Instead of introducing a series of statistical techniques, the book's organizational structure follows the order in which numerical information and statistical analyses are used in trials and new drug development.All students taking classes in pharmaceutical sciences and clinical research need a solid knowledge and understanding of the nature, methods, application and importance of Statistics. They need to understand:why, and how data are collected in clinical trials; how these data are summarized and analyzed; what the results mean in the context of the clinical research question; and, how the results are communicated to regulatory agencies and to scientific and medical communities.This title therefore adopts a unique approach and concept in organization of the content. It begins with an introduction to statistical theory, analysis and interpretation. This is followed by a discussion of t-tests and confidence intervals. Readers are then taken through the whole process of new drug development (using one specific example throughout) that is meaningful in the context of their broader studies. Throughout this process, statistical techniques and analyses are introduced in the order in which they are employed during the process. The book's realistic scientific and progressive organization from pre-clinical trials to clinical pharmacology through clinical trials is novel, meaningful and educationally powerful. The book emphasizes the importance of descriptive statistics as well as inferential statistics, something that is rarely done. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CLINICAL TRIALS AS TOPIC |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Turner, J. Rick. |
| Relator term | co-author |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Library of Congress Classification |
| Koha item type | Books |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Source of acquisition | Cost, normal purchase price | Total checkouts | Full call number | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | Pharmacy | LRC - Main | National University - Manila | General Circulation | 10/03/2011 | Purchased - Megatexts | 3595.00 | GC R 853 .D87 2008 | NULIB000001220 | 05/20/2025 | c.1 | 05/20/2025 | Books |